{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:34:04Z","timestamp":1790732044629,"version":"4.1.0"},"publisher-location":"Singapore","reference-count":44,"publisher":"Springer Singapore","isbn-type":[{"value":"9789811581038","type":"print"},{"value":"9789811581045","type":"electronic"}],"license":[{"start":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T00:00:00Z","timestamp":1604707200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T00:00:00Z","timestamp":1604707200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1007\/978-981-15-8104-5_3","type":"book-chapter","created":{"date-parts":[[2020,11,6]],"date-time":"2020-11-06T04:33:38Z","timestamp":1604637218000},"page":"43-52","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Histone H3K27M Mutation in Brain Tumors"],"prefix":"10.1007","author":[{"given":"Ahmed H. K.","family":"El-Hashash","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,7]]},"reference":[{"key":"3_CR1","volume-title":"Lehninger principles of biochemistry","author":"M Cox","year":"2005","unstructured":"Cox M, Nelson DR, Lehninger AL (2005) Lehninger principles of biochemistry. W.H. Freeman, San Francisco"},{"issue":"2","key":"3_CR2","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S0959-437X(02)00282-4","volume":"12","author":"C Redon","year":"2002","unstructured":"Redon C, Pilch D, Rogakou E, Sedelnikova O, Newrock K, Bonner W (2002) Histone H2A variants H2AX and H2AZ. Curr Opin Genet Dev 12(2):162\u2013169","journal-title":"Curr Opin Genet Dev"},{"key":"3_CR3","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/s40495-018-0141-6","volume":"4","author":"YCE Wan","year":"2018","unstructured":"Wan YCE, Liu J, Kui Ming Chan KM (2018) Histone H3 mutations in cancer. Curr Pharmacol Rep 4:292\u2013300","journal-title":"Curr Pharmacol Rep"},{"issue":"5","key":"3_CR4","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.cell.2010.01.003","volume":"140","author":"AD Goldberg","year":"2010","unstructured":"Goldberg AD, Banaszynski LA, Noh KM, Lewis PW, Elsaesser SJ, Stadler S et al (2010) Distinct factors control histone variant H3.3 localization at specific genomic regions. Cell 140(5):678\u2013691","journal-title":"Cell"},{"issue":"1","key":"3_CR5","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0092-8674(03)01064-X","volume":"116","author":"H Tagami","year":"2004","unstructured":"Tagami H, Ray-Gallet D, Almouzni G, Nakatani Y (2004) Histone H3.1 and H3.3 complexes mediate nucleosome assembly pathways dependent or independent of DNA synthesis. Cell 116(1):51\u201361","journal-title":"Cell"},{"issue":"4","key":"3_CR6","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ccr.2012.08.024","volume":"22","author":"D Sturm","year":"2012","unstructured":"Sturm D, Witt H, Hovestadt V, Khuong-Quang D-A, Jones DTW, Konermann C et al (2012) Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell 22(4):425\u2013437","journal-title":"Cancer Cell"},{"issue":"7","key":"3_CR7","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/nrclinonc.2012.87","volume":"9","author":"C Jones","year":"2012","unstructured":"Jones C, Perryman L, Hargrave D (2012) Paediatric and adult malignant glioma: close relatives or distant cousins? Nat Rev Clin Oncol Nat Publ Group 9(7):400\u2013413","journal-title":"Nat Rev Clin Oncol Nat Publ Group"},{"issue":"7384","key":"3_CR8","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nature10833","volume":"482","author":"J Schwartzentruber","year":"2012","unstructured":"Schwartzentruber J, Korshunov A, Liu X-Y, Jones DTW, Pfaff E, Jacob K et al (2012) Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 482(7384):226\u2013231","journal-title":"Nature"},{"issue":"3","key":"3_CR9","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/ng.1102","volume":"44","author":"G Wu","year":"2012","unstructured":"Wu G, Broniscer A, McEachron TA, Lu C, Paugh BS, Becksfort J et al (2012) Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat Genet 44(3):251\u2013253","journal-title":"Nat Genet"},{"issue":"6","key":"3_CR10","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1007\/s00401-015-1478-0","volume":"130","author":"D Castel","year":"2015","unstructured":"Castel D, Philippe C, Calmon R, Le Dret L, Truffaux N, Boddaert N et al (2015) Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes. Acta Neuropathol 130(6):815\u2013827","journal-title":"Acta Neuropathol"},{"issue":"5","key":"3_CR11","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/ng.2950","volume":"46","author":"AM Fontebasso","year":"2014","unstructured":"Fontebasso AM, Papillon-Cavanagh S, Schwartzentruber J, Nikbakht H, Gerges N, Fiset PO et al (2014) Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma. Nat Genet Nat Publ Group 46(5):462\u2013466","journal-title":"Nat Genet Nat Publ Group"},{"issue":"4","key":"3_CR12","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.ccell.2017.08.017","volume":"32","author":"A Mackay","year":"2017","unstructured":"Mackay A, Burford A, Carvalho D, Izquierdo E, Fazal-Salom J, Taylor KR et al (2017) Integrated molecular meta-analysis of 1,000 pediatric high-grade and diffuse intrinsic pontine glioma. Cancer Cell 32(4):520\u2013537.e5","journal-title":"Cancer Cell"},{"issue":"5","key":"3_CR13","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/ng.2925","volume":"46","author":"KR Taylor","year":"2014","unstructured":"Taylor KR, Mackay A, Truffaux N, Butterfield YS, Morozova O, Philippe C et al (2014) Recurrent activatingACVR1mutations in diffuse intrinsic pontine glioma. Nat Genet Nat Publ Group 46(5):457\u2013461","journal-title":"Nat Genet Nat Publ Group"},{"issue":"5","key":"3_CR14","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/ng.2938","volume":"46","author":"G Wu","year":"2014","unstructured":"Wu G, Diaz AK, Paugh BS, Rankin SL, Ju B, Li Y et al (2014) The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma. Nat Genet 46(5):444\u2013450","journal-title":"Nat Genet"},{"issue":"98","key":"3_CR15","doi-asserted-by":"publisher","first-page":"37112","DOI":"10.18632\/oncotarget.26430","volume":"9","author":"T Huang","year":"2018","unstructured":"Huang T, Garcia R, Qi J, Lulla R, Horbinski C, Behdad A, Wadhwani N, Shilatifard A, James C, Saratsis AM (2018) Detection of histone H3 K27M mutation and post-translational modifications in pediatric diffuse midline glioma via tissue immunohistochemistry informs diagnosis and clinical outcomes. Oncotarget 9(98):37112\u201337124","journal-title":"Oncotarget"},{"issue":"2","key":"3_CR16","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.gde.2004.02.001","volume":"14","author":"R Cao","year":"2004","unstructured":"Cao R, Zhang Y (2004) The functions of E(Z)\/EZH2-mediated methylation of lysine 27 in histone H3. Curr Opin Genet Dev 14(2):155\u2013164","journal-title":"Curr Opin Genet Dev"},{"issue":"18","key":"3_CR17","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1242\/dev.037127","volume":"136","author":"F Tie","year":"2009","unstructured":"Tie F, Banerjee R, Stratton CA, Prasad-Sinha J, Stepanik V, Zlobin A et al (2009) CBP-mediated acetylation of histone H3 lysine 27 antagonizes Drosophila polycomb silencing. Development 136(18):3131\u20133141","journal-title":"Development"},{"issue":"6134","key":"3_CR18","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1126\/science.1232245","volume":"340","author":"PW Lewis","year":"2013","unstructured":"Lewis PW, M\u00fcller MM, Koletsky MS, Cordero F, Lin S, Banaszynski LA et al (2013) Inhibition of PRC2 activity by a gain-of-function H3 mutation found in pediatric glioblastoma. Science 340(6134):857\u2013861","journal-title":"Science"},{"issue":"5","key":"3_CR19","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.ccr.2013.10.006","volume":"24","author":"S Bender","year":"2013","unstructured":"Bender S, Tang Y, Lindroth AM, Hovestadt V, Jones DTW, Kool M et al (2013) Reduced H3K27me3 and DNA Hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas. Cancer Cell 24(5):660\u2013672","journal-title":"Cancer Cell"},{"key":"3_CR20","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1101\/gad.217778.113","volume":"27","author":"K Chan","year":"2013","unstructured":"Chan K, Fang D, Gan H, Dev G, Chan K, Fang D et al (2013) The histone H3.3K27M mutation in pediatric glioma reprogramsH3K27 methylation and gene expression. Genes Dev 27:985\u2013990","journal-title":"Genes Dev"},{"issue":"16","key":"3_CR21","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.4161\/cc.25625","volume":"12","author":"KM Chan","year":"2013","unstructured":"Chan KM, Han J, Fang D, Gan H, Zhang Z (2013) A lesson learned from theH3.3K27 Mutation found in pediatric glioma. Anew approach to the study of the function of histone modifications in vivo? Cell Cycle 12(16):2546\u20132552","journal-title":"Cell Cycle"},{"issue":"6200","key":"3_CR22","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1126\/science.1255104","volume":"345","author":"HM Herz","year":"2014","unstructured":"Herz HM, Morgan M, Gao X, Jackson J, Rickels R, Swanson SK et al (2014) Histone H3 lysine-to-methionine mutants as a paradigm to study chromatin signaling. Science 345(6200):1065\u20131070","journal-title":"Science"},{"issue":"4","key":"3_CR23","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nm.4296","volume":"23","author":"A Piunti","year":"2017","unstructured":"Piunti A, Hashizume R, Morgan MA, Bartom ET, Horbinski CM, Marshall SA et al (2017) Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas. Nat Med 23(4):493\u2013500","journal-title":"Nat Med"},{"issue":"4","key":"3_CR24","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/nm.4293","volume":"23","author":"F Mohammad","year":"2017","unstructured":"Mohammad F, Weissmann S, Leblanc B, Pandey DP, Hojfeldt JW, Comet I et al (2017) EZH2 is a potential therapeutic target for H3K27M mutant pediatric gliomas. Nat Med 23(4):483\u2013492","journal-title":"Nat Med"},{"key":"3_CR25","doi-asserted-by":"publisher","first-page":"11316","DOI":"10.1038\/ncomms11316","volume":"7","author":"N Justin","year":"2016","unstructured":"Justin N, Zhang Y, Tarricone C, Martin SR, Chen S, Underwood E et al (2016) Structural basis of oncogenic histone H3K27M inhibition of human polycomb repressive complex 2. Nat Commun 7:11316","journal-title":"Nat Commun"},{"issue":"1","key":"3_CR26","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1038\/s41467-019-09981-6","volume":"10","author":"SU Jain","year":"2019","unstructured":"Jain SU, Do TJ, Lund PJ et al (2019) PFA ependymoma-associated protein EZHIP inhibits PRC2 activity through a H3 K27M-like mechanism. Nat Commun 10(1):2146","journal-title":"Nat Commun"},{"issue":"1","key":"3_CR27","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","volume":"17","author":"RGW Verhaak","year":"2010","unstructured":"Verhaak RGW, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD et al (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17(1):98\u2013110","journal-title":"Cancer Cell"},{"issue":"8","key":"3_CR28","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1200\/JCO.2009.25.5463","volume":"28","author":"M Zarghooni","year":"2010","unstructured":"Zarghooni M, Bartels U, Lee E, Buczkowicz P, Morrison A, Huang A et al (2010) Whole-genome profiling of pediatric diffuse intrinsic pontine gliomas highlights platelet-derived growth factor receptor \u03b1 and poly (ADP-ribose) polymerase as potential therapeutic targets. J Clin Oncol 28(8):1337\u20131344","journal-title":"J Clin Oncol"},{"key":"3_CR29","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.215525","volume":"131","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Chang JF, Sun J, Chen L, Yang XM, Tang HY, Jing YY, Kang X, He ZM, Wu JY, Wei HM, Wang DL, Xu RG, Zhu RB, Shen Y, Zeng SY, Wang C, Liu KN, Zhang Y, Mao ZY, Jiang CZ, Sun FL (2018) Histone H3K27 methylation modulates the dynamics of FANCD2 on chromatin to facilitate NHEJ and genome stability. J Cell Sci 131:jcs215525","journal-title":"J Cell Sci"},{"issue":"10","key":"3_CR30","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1101\/gad.2037511","volume":"25","author":"A Deaton","year":"2011","unstructured":"Deaton A, Bird A (2011) CpG islands and the regulation of transcription. Genes Dev 25(10):1010\u20131022","journal-title":"Genes Dev"},{"issue":"23","key":"3_CR31","doi-asserted-by":"publisher","first-page":"11045","DOI":"10.1073\/pnas.91.23.11045","volume":"91","author":"A Okamoto","year":"1994","unstructured":"Okamoto A, Demetrick DJ, Spillare EA, Hagiwara K, Hussain SP, Bennett WP et al (1994) Mutations and altered expression of p16INK4 in human cancer. Proc Natl Acad Sci U S A 91(23):11045","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"3_CR32","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.cell.2013.09.034","volume":"155","author":"CW Brennan","year":"2013","unstructured":"Brennan CW, Verhaak RGW, McKenna A, Campos B, Noushmehr H, Salama SR et al (2013) The somatic genomic landscape of glioblastoma. Cell 155(2):462\u2013477","journal-title":"Cell"},{"issue":"23\u201324","key":"3_CR33","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1101\/gad.309013.117","volume":"31","author":"F Mohammad","year":"2017","unstructured":"Mohammad F, Helin K (2017) Oncohistones: drivers of pediatric cancers. Genes Dev 31(23\u201324):2313\u20132324","journal-title":"Genes Dev"},{"issue":"9","key":"3_CR34","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1158\/1541-7786.MCR-16-0389","volume":"15","author":"FJ Cordero","year":"2017","unstructured":"Cordero FJ, Huang Z, Grenier C, He X, Hu G, McLendon RE et al (2017) Histone H3.3K27M represses p16 to accelerate gliomagenesis in a murine model of DIPG. Mol Cancer Res 15(9):1243\u20131254","journal-title":"Mol Cancer Res"},{"issue":"1","key":"3_CR35","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/s41467-019-08823-9","volume":"10","author":"CM Hoeman","year":"2019","unstructured":"Hoeman CM, Cordero FJ, Hu G et al (2019) ACVR1 R206H cooperates with H3.1K27M in promoting diffuse intrinsic pontine glioma pathogenesis. Nat Commun 10(1):1023","journal-title":"Nat Commun"},{"issue":"5","key":"3_CR36","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.ccell.2017.09.014","volume":"32","author":"M Pathania","year":"2017","unstructured":"Pathania M, De Jay N, Maestro N, Harutyunyan AS, Nitarska J, Pahlavan P et al (2017) H3.3 K27M cooperates with Trp53 loss and PDGFRA gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas. Cancer Cell 32(5):684\u2013700.e9","journal-title":"Cancer Cell"},{"issue":"6","key":"3_CR37","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/nm.3855","volume":"21","author":"CS Grasso","year":"2015","unstructured":"Grasso CS, Tang Y, Truffaux N, Berlow NE, Liu L, Debily MA et al (2015) Functionally defined therapeutic targets in diffuse intrinsic pontine glioma. Nat Med 21(6):555\u2013559","journal-title":"Nat Med"},{"issue":"12","key":"3_CR38","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1038\/nm.3716","volume":"20","author":"R Hashizume","year":"2014","unstructured":"Hashizume R, Andor N, Ihara Y, Lerner R, Gan H, Chen X et al (2014) Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma. Nat Med 20(12):1394\u20131396","journal-title":"Nat Med"},{"issue":"7520","key":"3_CR39","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1038\/nature13688","volume":"514","author":"B Heinemann","year":"2014","unstructured":"Heinemann B, Nielsen JM, Hudlebusch HR, Lees MJ, Larsen DV, Boesen T et al (2014) Inhibition of demethylases by GSK-J1\/J4. Nature 514(7520):E1\u2013E2","journal-title":"Nature"},{"issue":"7163","key":"3_CR40","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nature06145","volume":"449","author":"K Agger","year":"2007","unstructured":"Agger K, Cloos PAC, Christensen J, Pasini D, Rose S, Rappsilber J et al (2007) UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development. Nature 449(7163):731\u2013734","journal-title":"Nature"},{"issue":"2","key":"3_CR41","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/ng.518","volume":"42","author":"RD Morin","year":"2010","unstructured":"Morin RD, Johnson NA, Severson TM, Mungall AJ, An J, Goya R et al (2010) Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nat Genet 42(2):181\u2013185","journal-title":"Nat Genet"},{"issue":"46","key":"3_CR42","doi-asserted-by":"publisher","first-page":"5699","DOI":"10.1038\/onc.2015.24","volume":"34","author":"N Kanu","year":"2015","unstructured":"Kanu N, Gr\u00f6nroos E, Martinez P, Burrell RA, Yi Goh X, Bartkova J et al (2015) SETD2 loss-of-function promotes renal cancer branched evolution through replication stress and impaired DNA repair. Oncogene 34(46):5699\u20135708","journal-title":"Oncogene"},{"issue":"20","key":"3_CR43","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1182\/blood-2017-03-774653","volume":"130","author":"B Lehnertz","year":"2017","unstructured":"Lehnertz B, Zhang YW, Boivin I, Mayotte N, Tomellini E, Chagraoui J et al (2017) H3K27M\/Imutations promote context dependent transformation in acute myeloid leukemia with RUNX1 alterations. Blood 130(20):2204\u20132214","journal-title":"Blood"},{"issue":"7","key":"3_CR44","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrc2876","volume":"10","author":"P Chi","year":"2010","unstructured":"Chi P, Allis CD, Wang GG (2010) Covalent histone modifications \u2014 miswritten, misinterpreted and mis-erased in human cancers. Nat Rev Cancer 10(7):457\u2013469","journal-title":"Nat Rev Cancer"}],"container-title":["Advances in Experimental Medicine and Biology","Histone Mutations and Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-15-8104-5_3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T00:07:39Z","timestamp":1674778059000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-981-15-8104-5_3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,7]]},"ISBN":["9789811581038","9789811581045"],"references-count":44,"URL":"https:\/\/doi.org\/10.1007\/978-981-15-8104-5_3","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,7]]},"assertion":[{"value":"7 November 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}